Title: Rimegepant 75 mg is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Results From 3 Phase 3 Trials (1212)
Abstract: Monday, April 27April 14, 2020Free AccessRimegepant 75 mg is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Results From 3 Phase 3 Trials (1212)Morris Levin, Dawn Buse, Andrew Blumenfeld, Richard Lipton, Elyse Stock, Alexandra Thiry, Charlie Conway, Christopher Jensen, Beth Morris, Vladimir Coric, and Robert CroopAuthors Info & AffiliationsApril 14, 2020 issue94 (15_supplement)https://doi.org/10.1212/WNL.94.15_supplement.1212 Letters to the Editor
Publication Year: 2020
Publication Date: 2020-04-14
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
Cited By Count: 2
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot